Helping Nephrologists Succeed in Value-Based Care

Leverage the strength of collaborative, physician leadership.

Nephrology Care Alliance (NCA) is a set of local physician-led and physician-governed entities with an experienced national team to help bring nephrologists opportunities to participate in value-based care (VBC) contracts, enhanced tools and capabilities, and the collaboration to support their ongoing success. NCA exists to help nephrologists make the transition to and win in VBC.

Value-Based Care is Here

It's a dynamic time for nephrology. Rising health care costs have payors looking to physicians to take more accountability and financial risk for chronic kidney disease (CKD) and end stage kidney disease (ESKD) care in order to help reduce avoidable health care costs.

NCA empowers nephrologists to succeed in VBC by offering:

Value-Based
Care Contracts

NCA provides information and support around different value-based care (VBC) programs from the government (such as Kidney Care First) and from commercial insurance companies. NCA’s Clinical Incentive Program, which can be applied to government and other payor models, enables physicians an entry point for participation to help start the journey towards VBC.


Tools & Capabilities

Critical capabilities to help achieve value-based metrics that may not be easily available at the practice level. Leverage advanced analytics and reporting, award-winning patient education tools, advisory and administrative support, supplemental care resources (as needed), and more.

Collaboration with
Nephrologists

Collaboration is core to NCA’s strategy. NCA supports and encourages local nephrologist communities to promote best practice sharing and clinical collaboration. This nephrologist-led platform grants access to additional expertise nephrologists and practices may not have on their own.

Leading Expertise and Results


10+

years of experience in CKD care management

35K+

managed CKD patients1

93%

of patients engaged with a nephrologist by the time they transition to kidney failure2

74%

of ESKD patients transition with optimal vascular access instead of central venous catheter (CVC)3,4

72%

of ESKD patients transition to dialysis in an outpatient setting vs. the hospital5

38%

fewer hospital admits for ESKD patients in the first 180 days of dialysis6

Kidney Disease Education

Our Kidney Disease Education (KDE) resource offers modules designed to meet your patient needs. Customize content based on patient comorbidities to help promote interaction with your patients and offer better education for better health outcomes. Access KDE education below.


Physician Leadership

The physician advisory board provides valuable insight as we work together to revolutionize chronic kidney disease (CKD) care. Board members' clinical, academic, and policy expertise guide the development of programs, tools, and services to help you overcome challenges in CKD.

Meet the Physicians
1. 35,000 patients served in total over more than 10 years of CKD care management. | 2. Vs. 36% baseline. Based on data through Q3 2018 for CKD population managed at least 180 days prior to transition (DaVita IKC analysis). | 3. Vs. 40% baseline.Transitions claims data 2016-2018 | 4. Non-CVC access. CVC access is associated with a higher rate of infection. | 5. Vs. 27% baseline.Transition claims data 2016–2018 and CMS 5% sample from 2014–2016. | 6. DaVita IKC internal data compared to USRDS baselines or internal baselines where appropriate. | 7. Digital Health Awards Winner, Hermes Creative Awards 2019 Platinum, 2019 AVA Digital Awards Platinum Winner.

To learn more, please contact us at NCASupport@davita.com.